Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Lasers Can Aid Retrieval of Stubborn IVC Filters

Caitlin E. Cox

December 02, 2020

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

L.A. McKeown

February 26, 2014

News Daily News

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

L.A. McKeown

February 26, 2014

Advertisement

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

TCTMD’s Top 10 Most Popular Stories for September 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

BP Reduction With Renal Denervation Still Evident a Decade On

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Lasers Can Aid Retrieval of Stubborn IVC Filters

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content